Our observations suggest that in some cases the PPARγ network is stimulated to help ovarian cancer cells survive as suggested by Rosiglitazone treatment increasing the IC50s of MT19c and cisplatin. The gene discussed is PPARG; the disease is ovarian carcinoma.